On March 21, 2024, The Chemours Company was sued for violations of the federal securities laws in the United States District Court for the District of Delaware on behalf of investors who purchased or otherwise acquired the Company’s shares between February 10, 2023, and February 28, 2024, inclusive (the “Class Period”).
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.